T2DM and obesity are states of hyperinsulinemia, and insulin is known to directly activate IGF1-R on epidermal cells and increase IGF1 levels in the blood, which is the proposed mechanism of action of AN in hyperinsulinemic states [5]. This evidence concerns the gene IGF1R and obesity due to melanocortin 4 receptor deficiency.